ArticleFrontiers in pharmacology2020

α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines.

Xiao-Feng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.